Hamad Almutlaq

1PUBLICATIONS
0CO-AUTHORS
Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Sep 27, 2026
Short-Term Cost per Responder of Lebrikizumab versus Tralokinumab for Moderate-to-Severe Atopic Dermatitis in Saudi Arabia: A Model-Based Payer Analysis.

Pageof 1

Frequent Collaborators